AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8672385 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine-bupivacaine mixture (2% lignocaine and 0.75% bupivacaine)
Number of subjects: 90
Study 1429318 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent reinforcement group (received music for productive behavior)
Number of subjects: 6
Study 1429318 — intervention group
Group type: COMPARATOR
Intervention: Noncontingent group (received music regardless of training productivity)
Number of subjects: 6
Study 3001015 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulbactam/ampicillin
Number of subjects: 0
Study 3001015 — intervention group
Group type: COMPARATOR
Intervention: Flucloxacillin/ampicillin
Number of subjects: 0
Study 31414914 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI at 20 years
Number of subjects: 145544
Study 31414914 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI at 50 years
Number of subjects: 145544
Study 31414914 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI at enrolment
Number of subjects: 145544
Study 31414914 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal BMI at age 20 then became overweight at age 50
Number of subjects: 145544
Study 31414914 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal BMI at age 20 then became obese at age 50
Number of subjects: 145544
Study 29428865 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-control task
Number of subjects: 84
Study 29428865 — intervention group
Group type: COMPARATOR
Intervention: Neutral task
Number of subjects: 84
Study 27138798 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram, Sertraline, or Venlafaxine (8 weeks treatment, dosage adjusted by clinician)
Number of subjects: 1008
Study 27138798 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (8 weeks treatment, dosage adjusted by clinician)
Number of subjects: 1008
Study 25816629 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet (LCD) 1600-1700 kcal/day
Number of subjects: 174
Study 25816629 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric diet (ICD) 2500-2700 kcal/day
Number of subjects: 174
Study 22541248 — intervention group
Group type: EXPERIMENTAL
Intervention: pitrakinra (1, 3, or 10 mg twice daily)
Number of subjects: 407
Study 22541248 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 407
Study 19850637 — intervention group
Group type: EXPERIMENTAL
Intervention: sorafenib (400 mg b.i.d.)
Number of subjects: 139
Study 19850637 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 139
Study 18630549 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Chinese and western medicine group
Number of subjects: 75
Study 18630549 — intervention group
Group type: COMPARATOR
Intervention: Traditional Chinese medicine (TCM) group
Number of subjects: 75
Study 18630549 — intervention group
Group type: COMPARATOR
Intervention: Western medicine group
Number of subjects: 75
Study 16049627 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual Meditation
Number of subjects: 0
Study 16049627 — intervention group
Group type: COMPARATOR
Intervention: Secular Meditation
Number of subjects: 0
Study 16049627 — intervention group
Group type: COMPARATOR
Intervention: Relaxation
Number of subjects: 0
Study 12238266 — intervention group
Group type: COMPARATOR
Intervention: 0.5 mg/kg atracurium (group A)
Number of subjects: 84
Study 12238266 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 mg/kg cis-atracurium (group C)
Number of subjects: 84
Study 10202317 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilevel positive airway pressure (BiPAP) with EPAP = 8 cm H2O and IPAP = 12 cm H2O
Number of subjects: 27
Study 10202317 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilevel positive airway pressure (BiPAP) with EPAP = 10 cm H2O and IPAP = 15 cm H2O
Number of subjects: 27
Study 10202317 — intervention group
Group type: COMPARATOR
Intervention: Continuous positive airway pressure (CPAP) with EPAP = IPAP = 10 cm H2O
Number of subjects: 27
Study 8533508 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin administration
Number of subjects: 0
Study 8533508 — intervention group
Group type: COMPARATOR
Intervention: Placebo intake
Number of subjects: 0
Study 2140251 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 75 mg dipyridamole with 330 mg acetylsalicylic acid (ASA) tid (high dose)
Number of subjects: 199
Study 2140251 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 75 mg dipyridamole with 100 mg acetylsalicylic acid (ASA) tid (low dose)
Number of subjects: 199
Study 2140251 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 199
Study 66425 — intervention group
Group type: EXPERIMENTAL
Intervention: H2-receptor antagonists (metiamide and cimetidine)
Number of subjects: 75
Study 66425 — intervention group
Group type: COMPARATOR
Intervention: Control (antacids)
Number of subjects: 75
Study 66425 — intervention group
Group type: EXPERIMENTAL
Intervention: H2-receptor antagonists
Number of subjects: 75
Study 31727675 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 553
Study 31727675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 553
Study 30835950 — intervention group
Group type: EXPERIMENTAL
Intervention: TCZ-QW + Pred-26
Number of subjects: 250
Study 30835950 — intervention group
Group type: EXPERIMENTAL
Intervention: TCZ-Q2W + Pred-26
Number of subjects: 250
Study 30835950 — intervention group
Group type: COMPARATOR
Intervention: PBO + Pred-26
Number of subjects: 250
Study 30835950 — intervention group
Group type: COMPARATOR
Intervention: PBO + Pred-52
Number of subjects: 250
Study 28298396 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy group (low-fat milk or yogurt servings providing ≥1200 mg Ca/d)
Number of subjects: 274
Study 28298396 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual diet of ≤600 mg Ca/d)
Number of subjects: 274
Study 28298396 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy group
Number of subjects: 274
Study 28298396 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 274
Study 25577134 — intervention group
Group type: EXPERIMENTAL
Intervention: XELOXIRI/bevacizumab regimen (oxaliplatin 100 mg/m², capecitabine 1,700 mg/m²/day, irinotecan 150 mg/m², bevacizumab 7.5 mg/kg)
Number of subjects: 12
Study 25577134 — intervention group
Group type: EXPERIMENTAL
Intervention: XELOXIRI/bevacizumab regimen
Number of subjects: 12
Study 23863946 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotic symptoms (attenuated or frank)
Number of subjects: 1112
Study 23863946 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotic symptoms among adolescents with baseline psychopathology
Number of subjects: 1112
Study 19949772 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate 70 mg/week for 3 months
Number of subjects: 35
Study 19949772 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy: Alendronate 70 mg/week, vitamin D 2800 IU/week, and calcium 1 g/day for 12 months
Number of subjects: 35
Study 19949772 — intervention group
Group type: COMPARATOR
Intervention: Calcium 1 g/day and vitamin D 800 IU/day
Number of subjects: 35
Study 18308815 — intervention group
Group type: EXPERIMENTAL
Intervention: Betel-quid
Number of subjects: 20
Study 18308815 — intervention group
Group type: COMPARATOR
Intervention: Chewing gum
Number of subjects: 20
Study 15701301 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary and alternative medicines (CAM)
Number of subjects: 0
Study 15701301 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 14501546 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic back massage (TBM)
Number of subjects: 42
Study 10391658 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Scale for the Elderly (PASE)
Number of subjects: 190
Study 8905958 — intervention group
Group type: COMPARATOR
Intervention: Standard tube (group S, n = 14)
Number of subjects: 37
Study 8905958 — intervention group
Group type: EXPERIMENTAL
Intervention: Gas barrier type tube (group G, n = 11)
Number of subjects: 37
Study 8905958 — intervention group
Group type: EXPERIMENTAL
Intervention: Brandt tube (group B, n = 12)
Number of subjects: 37
Study 1868811 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigabatrin (GVG)
Number of subjects: 33
Study 1868811 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 6604680 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C supplements (500 mg/day i.m. for 1 month)
Number of subjects: 0
Study 6604680 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29601918 — intervention group
Group type: EXPERIMENTAL
Intervention: Active continuous theta-burst stimulation (cTBS) targeting the left dlPFC
Number of subjects: 58
Study 29601918 — intervention group
Group type: COMPARATOR
Intervention: Sham continuous theta-burst stimulation (cTBS)
Number of subjects: 58
Study 27599896 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-opioid
Number of subjects: 182
Study 27599896 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine
Number of subjects: 182
Study 27599896 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone
Number of subjects: 182
Study 24639273 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive formula feeding
Number of subjects: 863
Study 24639273 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding
Number of subjects: 863
Study 24639273 — intervention group
Group type: EXPERIMENTAL
Intervention: Introduction of solid food
Number of subjects: 863
Study 24639273 — intervention group
Group type: EXPERIMENTAL
Intervention: Putting infants to bed with bottles
Number of subjects: 863
Study 24639273 — intervention group
Group type: EXPERIMENTAL
Intervention: Propping bottles
Number of subjects: 863
Study 24639273 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding when the infant cried
Number of subjects: 863
Study 24639273 — intervention group
Group type: EXPERIMENTAL
Intervention: Trying to get children to finish milk
Number of subjects: 863
Study 24639273 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to television
Number of subjects: 863
Study 24639273 — intervention group
Group type: EXPERIMENTAL
Intervention: Active television watching
Number of subjects: 863
Study 24639273 — intervention group
Group type: EXPERIMENTAL
Intervention: Meeting tummy time recommendations
Number of subjects: 863
Study 24639273 — intervention group
Group type: COMPARATOR
Intervention: Black parents putting children to bed with a bottle
Number of subjects: 863
Study 24639273 — intervention group
Group type: COMPARATOR
Intervention: Black parents propping bottles
Number of subjects: 863
Study 24639273 — intervention group
Group type: COMPARATOR
Intervention: Black parents reporting more television watching
Number of subjects: 863
Study 24639273 — intervention group
Group type: COMPARATOR
Intervention: Hispanic parents encouraging children to finish feeding
Number of subjects: 863
Study 24639273 — intervention group
Group type: COMPARATOR
Intervention: Hispanic parents propping bottles
Number of subjects: 863
Study 24639273 — intervention group
Group type: COMPARATOR
Intervention: Hispanic parents reporting less tummy time
Number of subjects: 863
Study 25276736 — intervention group
Group type: EXPERIMENTAL
Intervention: Aloe vera and Calendula Ointment every 8 hours for 5 days
Number of subjects: 111
Study 25276736 — intervention group
Group type: COMPARATOR
Intervention: Hospital routine care for episiotomy for 5 days
Number of subjects: 111
Study 21906812 — intervention group
Group type: EXPERIMENTAL
Intervention: Torasemide-PR
Number of subjects: 155
Study 21906812 — intervention group
Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 155
Study 18219235 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (up to 400 mg)
Number of subjects: 53
Study 18219235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study 16622537 — intervention group
Group type: EXPERIMENTAL
Intervention: Directed exercise group (19 exercises regimen)
Number of subjects: 60
Study 16622537 — intervention group
Group type: COMPARATOR
Intervention: Free exercise group (biomechanical movements without defined sequence)
Number of subjects: 60
Study 14768844 — intervention group
Group type: EXPERIMENTAL
Intervention: Arousal at 60% of maximum heart rate reserve
Number of subjects: 104
Study 14768844 — intervention group
Group type: EXPERIMENTAL
Intervention: Arousal at 70% of maximum heart rate reserve
Number of subjects: 104
Study 14768844 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatic anxiety as measured by the Sport Anxiety Scale (SAS)
Number of subjects: 104
Study 14768844 — intervention group
Group type: EXPERIMENTAL
Intervention: Arousal (general)
Number of subjects: 104
Study 11030488 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 221
Study 11030488 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 221
Study 8857856 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose adenosine cardioplegia
Number of subjects: 63
Study 2000739 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic and antithrombotic treatment (streptokinase initiated late, heparin infusion for at least 5 days, warfarin and dipyridamole for at least 3 months)
Number of subjects: 255
Study 2000739 — intervention group
Group type: COMPARATOR
Intervention: Control group (routine treatment)
Number of subjects: 255
Study 6391075 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (prostaglandin-inhibitor)
Number of subjects: 0
Study 6391075 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30273591 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon-assisted colonoscopy
Number of subjects: 803
Study 30273591 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscopy
Number of subjects: 803
Study 29885045 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost infusion
Number of subjects: 12
Study 29885045 — intervention group
Group type: COMPARATOR
Intervention: Insulin infusion alone
Number of subjects: 12
Study 27464674 — intervention group
Group type: EXPERIMENTAL
Intervention: early adenotonsillectomy (eAT)
Number of subjects: 453
Study 27464674 — intervention group
Group type: COMPARATOR
Intervention: watchful waiting with supportive care
Number of subjects: 453
Study 25388563 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidopexy (SH)
Number of subjects: 338
Study 25388563 — intervention group
Group type: COMPARATOR
Intervention: Traditional haemorrhoidectomy (TH)
Number of subjects: 338
Study 22236501 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs) - omeprazole; n:19
Number of subjects: 78
Study 22236501 — intervention group
Group type: COMPARATOR
Intervention: Histamine H(2) -receptor antagonists (H(2) RAs) - ranitidine; n:16
Number of subjects: 78
Study 22236501 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitors (PPIs) - omeprazole; n:11 (previously H(2) RA nonresponders)
Number of subjects: 78
Study 22236501 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine H(2) -receptor antagonists (H(2) RAs) - ranitidine; n:1 (previously H(2) RA nonresponder)
Number of subjects: 78
Study 21199406 — intervention group
Group type: EXPERIMENTAL
Intervention: Active agent
Number of subjects: 67
Study 21199406 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 67
Study 18053382 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered medication (SAM)
Number of subjects: 345
Study 18053382 — intervention group
Group type: COMPARATOR
Intervention: Standard administration by nurses
Number of subjects: 345
Study 15817008 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention program including staff education and reorganization of care
Number of subjects: 400
Study 15817008 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention program
Number of subjects: 400
Study 14680716 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam and imipramine (placebo-controlled drug trial)
Number of subjects: 55
Study 10386282 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of droperidol 1.25 mg
Number of subjects: 120
Study 10386282 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of droperidol 1.25 mg
Number of subjects: 120
Study 10386282 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of droperidol 1.25 mg and ondansetron 4 mg in combination
Number of subjects: 120
Study 10386282 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of droperidol 1.25 mg and ondansetron 4 mg in combination
Number of subjects: 120
Study 8918277 — intervention group
Group type: EXPERIMENTAL
Intervention: High-impact exercise training (n = 49)
Number of subjects: 98
Study 8918277 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 49)
Number of subjects: 98
Study 2011945 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cyclosporin‐A (CyA) at 7.5 mg/kg
Number of subjects: 26
Study 2011945 — intervention group
Group type: COMPARATOR
Intervention: Oral prednisolone (decreasing doses from 0.8 mg/kg)
Number of subjects: 26
Study 6123079 — intervention group
Group type: EXPERIMENTAL
Intervention: At-home family therapy
Number of subjects: 36
Study 6123079 — intervention group
Group type: COMPARATOR
Intervention: Clinic-based individual supportive care
Number of subjects: 36
Study 31987974 — intervention group
Group type: EXPERIMENTAL
Intervention: 74 Gy in 37 fractions over 7.4 weeks
Number of subjects: 3216
Study 31987974 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 Gy in 20 fractions over 4 weeks
Number of subjects: 3216
Study 31987974 — intervention group
Group type: EXPERIMENTAL
Intervention: 57 Gy in 19 fractions over 3.8 weeks
Number of subjects: 3216
Study 31987974 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated schedules
Number of subjects: 3216
Study 31987974 — intervention group
Group type: COMPARATOR
Intervention: Control group (no symptoms at baseline or 1-5 years after radiation)
Number of subjects: 3216
Study 31427628 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (IG): individualized exercising program including aerobic exercise at least three times a week for >/=30 minutes, muscle training, and stretching
Number of subjects: 131
Study 31427628 — intervention group
Group type: COMPARATOR
Intervention: Reference group (RG)
Number of subjects: 131
Study 31427628 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (IG)
Number of subjects: 131
Study 31427628 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 131
Study 30309470 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher wall shear stress (WSSprox) in proximal segments of lesions
Number of subjects: 441
Study 30309470 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower fractional flow reserve (FFR)
Number of subjects: 441
Study 30309470 — intervention group
Group type: EXPERIMENTAL
Intervention: Adding WSSprox to FFR
Number of subjects: 441
Study 30309470 — intervention group
Group type: COMPARATOR
Intervention: Control group with no myocardial infarction (MI)
Number of subjects: 441
Study 26735845 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraRice_original
Number of subjects: 1977
Study 26735845 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraRice_improved
Number of subjects: 1977
Study 26735845 — intervention group
Group type: EXPERIMENTAL
Intervention: NutriRice
Number of subjects: 1977
Study 26735845 — intervention group
Group type: COMPARATOR
Intervention: Placebo rice
Number of subjects: 1977
Study 25137425 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 19
Study 25137425 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 19
Study 25137425 — intervention group
Group type: COMPARATOR
Intervention: HDL from controls
Number of subjects: 19
Study 25137425 — intervention group
Group type: COMPARATOR
Intervention: HDL from type 2 diabetic patients
Number of subjects: 19
Study 23063389 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraosseous anesthesia using Quicksleeper (IO injection)
Number of subjects: 40
Study 23063389 — intervention group
Group type: COMPARATOR
Intervention: Conventional inferior alveolar nerve block (IANB)
Number of subjects: 40
Study 19394471 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior-24-hour recalls
Number of subjects: 374
Study 19394471 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior-24-hour recalls in the afternoon and evening
Number of subjects: 374
Study 19394471 — intervention group
Group type: COMPARATOR
Intervention: Previous-day recalls
Number of subjects: 374
Study 17252462 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 118
Study 17252462 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation
Number of subjects: 118
Study 15826314 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone Dipropionate (QVAR) 100 mcg 2 puffs 2 times a day for 6 weeks
Number of subjects: 0
Study 15826314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12173271 — intervention group
Group type: EXPERIMENTAL
Intervention: Ole e 7 sensitization in patients with anaphylaxis (group B)
Number of subjects: 134
Study 12173271 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin prick test (SPT) against Olea europaea allergens
Number of subjects: 134
Study 12173271 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind placebo-controlled food challenge (DBPCFC)
Number of subjects: 134
Study 12173271 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive SPT to Rosaceae fruits and Ole e 3
Number of subjects: 134
Study 12173271 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive SPT to Cucurbitaceae and Ole e 7
Number of subjects: 134
Study 12173271 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive SPT to Actinidiaceae and Ole e 3
Number of subjects: 134
Study 9797484 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day (RLX60)
Number of subjects: 143
Study 9797484 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 120 mg/day (RLX120)
Number of subjects: 143
Study 9797484 — intervention group
Group type: COMPARATOR
Intervention: Control group (750 mg/day calcium and 400 IU/day vitamin D)
Number of subjects: 143
Study 9797484 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (both doses)
Number of subjects: 143
Study 7696061 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40
Study 7696061 — intervention group
Group type: COMPARATOR
Intervention: Etomidate-vecuronium-isoflurane
Number of subjects: 40